Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary progressive multiple sclerosis.

Xavier Montalban1

  • 1Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. xavier.montalban@unic-em.com

Current Opinion in Neurology
|May 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary event.

Frontiers in neurology·2024
Same author

IL-6 Inhibition as a Therapeutic Target in Aged Experimental Autoimmune Encephalomyelitis.

International journal of molecular sciences·2024
Same author

Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2024
Same author

Artificial intelligence applied to MRI data to tackle key challenges in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2024
Same author

Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial.

Journal of neurology·2024
Same author

Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.

Neurology·2024
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Primary progressive multiple sclerosis (PPMS) research shows normal-appearing brain tissue involvement. This finding aids in understanding PPMS and may include patients in future therapeutic trials.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Radiology

Background:

  • Primary progressive multiple sclerosis (PPMS) is a distinct clinical form of MS.
  • Understanding PPMS characteristics is crucial for diagnosis and treatment.
  • Ongoing scientific debate surrounds the specific features of PPMS.

Purpose of the Study:

  • To review the current scientific debate on the specific characteristics of primary progressive multiple sclerosis.
  • To synthesize recent findings on PPMS pathology and clinical presentation.

Main Methods:

  • Review of magnetic resonance imaging (MRI) studies.
  • Analysis of longitudinal clinical and MRI data.
  • Examination of results from exploratory therapeutic trials.

Related Experiment Videos

Main Results:

  • MRI studies reveal involvement of normal-appearing brain tissue in PPMS.
  • Longitudinal studies provide insights into the natural history of PPMS.
  • Damage to normal-appearing brain tissue may explain clinical-radiological paradoxes.

Conclusions:

  • Advances in PPMS diagnosis have been achieved.
  • The natural history of PPMS is better understood, facilitating future clinical trial design.
  • PPMS patients may soon be eligible for therapeutic trials, as preliminary results are promising.